DCF — MERCYONE WATERLOO MEDICAL CENTER
Enterprise Value: $-253.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-253.8M
Enterprise Value
$-84.8M
PV of Cash Flows
$-169.1M
PV of Terminal Value
$-272.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $291.8M | $-13.4M | -5.0% | $-25.7M | $-23.4M |
| Year 2 | $300.6M | $-10.8M | -4.0% | $-23.5M | $-19.4M |
| Year 3 | $309.6M | $-8.0M | -3.0% | $-21.1M | $-15.9M |
| Year 4 | $318.9M | $-6.6M | -2.0% | $-20.1M | $-13.8M |
| Year 5 | $328.5M | $-6.0M | -2.0% | $-19.9M | $-12.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-253.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$283.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05082537250529689
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5